Abstract
The orally disintegrating tablet (ODT) has shown vast potential as an alternative oral dosage form to conventional tablets wherein they can disintegrate rapidly (≤30 s) upon contact with saliva fluid and should have an acceptable mouthfeel as long as their weight doesn’t exceed 500 mg. However, owing to the bitterness of several active ingredients, there is a need to find a suitable alternative to ODTs that maintains their features and can be taste-masked more simply and inexpensively. Therefore, electrospun nanofibers and solvent-cast oral dispersible films (ODFs) are used in this study as potential OD formulations for prednisolone sodium phosphate (PSP) that is commercially available as ODTs. The encapsulation efficiency (EE%) of the ODFs was higher (≈100%) compared to the nanofibers (≈87%), while the disintegration time was considerably faster for the electrospun nanofibers (≈30 s) than the solvent-cast ODFs (≈700 s). Hence, accelerated release rate of PSP from the nanofibers was obtained, due to their higher surface area and characteristic surface morphology that permitted higher wettability and thus, faster erosion. Taste-assessment study using the electronic-tongue quantified the bitterness threshold of the drug and its aversiveness concentration (2.79 mM). Therefore, a taste-masking strategy would be useful when further formulating PSP as an OD formulation.
| Original language | English |
|---|---|
| Article number | 120 |
| Pages (from-to) | 1-17 |
| Number of pages | 17 |
| Journal | Pharmaceutics |
| Volume | 13 |
| Issue number | 1 |
| Early online date | 18 Jan 2021 |
| DOIs | |
| Publication status | Published - 18 Jan 2021 |
Data Availability Statement
All data are available upon request.Acknowledgements
The authors would like to thank the National Industrial Development andLogistics Program (NIDLP) through the Health Initiative and the Technology Leader Program Initiative, projects numbers 20-0103 and 20-0051 that supported E.A.T. Also, the authors would like to thank the Research Centre for Pharmaceutical Engineering GmbH (RCPE) Graz, Austria and UCL Impact Awards grants which supported M.S. H.E.A. is a PhD candidate funded by the Medical Research Council (iCASE award no. 170156) and Pfizer Ltd., Kent, UK (award no. 173803).
Funding
This research received no external funding.
Keywords
- Disintegration
- Dissolution
- E-tongue
- Electrospinning
- Electrospun nanofibers
- Orodispersible films (ODFs), prednisolone
- Solvent-casting
ASJC Scopus subject areas
- Pharmaceutical Science